Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

MSD updates Univadis, adds apps

New UK version of its HCP website will allow users to personalise the portal

Merck Sharp Dohme MSD Univadis appsMerck Sharp & Dohme (MSD) has relaunched the UK version of its healthcare professional website Univadis.

The new site adds a medical app library that allows users to personalise the portal, choosing from specialist disease information and clinical interests for more than 50 specialties.

Deepak Khanna, MSD's managing director, said: "Since the release of The Merck Manual more than 100 years ago, MSD has been committed to supporting doctors and healthcare professionals by providing non-promotional health information.

“MSD's ongoing dedication to providing high quality and state-of-the-art resources to medical audiences is exemplified by the re-development of Univadis, and is in line with MSD's vision of delivering innovative health solutions.”

Set up in 2001, Univadis.co.uk is free for healthcare professionals (HCPs) to access and includes content from leading medical journals such as The Lancet and the British Medical Journal.

The site's new range of medical applications offers access to medical news, accredited education courses, disease information and point-of-care tools.

Editor in Chief of Univadis in the UK, Dr Harry Brown says: “For all healthcare professionals, medical education is a vital aspect of ensuring the best patient care possible. 

“By offering high quality and accredited online education courses and other valuable resources to the medical community, Univadis can really make a difference to many practitioners in the United Kingdom.”

MSD is also hoping to carve out a niche for Univadis as a point-of-care tool for use during patient consultations, and the site now includes a bank more than 58,000 medical images and wide-ranging disease information the company hopes will “help inform patient-doctor conversations”.

In addition to its uses for healthcare professionals, MSD's parent company Merck & Co has talked in the past about how important the site is for its future, with increasing levels of trust with HCPs one of its key aims.

13th May 2013

From: Healthcare

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
The Difference Collective

Welcome to the Difference Collective – a healthcare communications team of 80+ talented experts who Deliver Differently. We’re purpose-built around...

Latest intelligence

When is an agency not an agency?
The PR Week UK Top 150 Consultancies prompts anticipation and curiosity. But can a virtual collective of freelancers fairly be compared and ranked against conventional agencies?...
Why big pharma needs to be braver
The last few years have seen the pharmaceutical industry undergo a rapid metamorphosis in the face of unprecedented change, but communications are one area that still needs an injection of...
Leveraging Real-World Evidence for Cell and Gene Therapies
Regulators and reimbursement bodies are increasingly turning to real-world evidence (RWE) to understand the long-term value of drugs, in particular novel therapies. Here, Mariam Bibi, Senior Director, Global RWE at...